USA TODAY on MSN: FDA asks drug manufacturer for more safety data on Foundayo GLP-1 Becker's Hospital Review: FDA seeks additional safety data for Lilly GLP-1 pill Eli Lilly says it has the safety data it needs to shore up the recent speedy approval of its oral obesity therapy Foundayo, and also to file the GLP-1 agonist for approval in type 2 diabetes later ... The Independent on MSN: FDA asks Eli Lilly for more safety info on new GLP-1 weight loss pill FDA asks drugmaker Eli Lilly for more safety information on its new GLP-1 weight loss pill - At the heart of the request is whether taking Foundayo - made with a new active ingredient called ... FDA asks Eli Lilly for more safety info on new GLP-1 weight loss pill The Providence Journal: Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development